» Articles » PMID: 34943348

Guided Growth in Leg Length Discrepancy in Beckwith-Wiedemann Syndrome: A Consecutive Case Series

Overview
Specialty Health Services
Date 2021 Dec 24
PMID 34943348
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Beckwith-Wiedemann Syndrome (BWS) is a rare genetic disorder characterized by overgrowth, macroglossia, abdominal wall defects, neonatal hypoglycemia, predisposition to embryonal tumor, lateralized overgrowth, and leg length discrepancy (LLD), which can affect normal posture and gait. Aim of this study was to evaluate the effects of guided growth (temporary epiphysiodesis technique) as LLD management in BWS patients. Between 2007 and 2021, 22 BWS patients (15 F, 7 M) with a mean age of 7.9 years (2.9-14.4) and a mean LLD at first surgery of 3.65 cm (2-10), underwent temporary proximal tibial (PTE) and distal femur epiphysiodesis (DFE). In 18 patients the first surgical procedure was PTE, in one, DFE, and in 3 cases, PTE and DFE at the same time, respectively. Eleven patients reached equality of leg length after a mean follow-up of 7.7 years (3.7-13.0) and mean age of 13.3 years (12.7-27.5); 10 patients underwent 3 surgical procedures, one 7 procedures. Fifteen patients had no complications. No severe complications, infection, articular stiffness, or neuro-vascular lesions occurred in remaining patients; complications included secondary varus or valgus axial deviation in a total of 6 patients, and two screw breakages in two patients. Guided growth as a minimally invasive procedure seems efficient for LLD treatment with low complication rate in BWS patients.

Citing Articles

Staples, tension-band plates, and percutaneous epiphysiodesis screws used for leg-length discrepancy treatment: a systematic review and proportional meta-analysis.

Tirta M, Hjorth M, Jepsen J, Kold S, Rahbek O Acta Orthop. 2024; 95:415-424.

PMID: 39023429 PMC: 11257069. DOI: 10.2340/17453674.2024.41104.


Work-Up and Treatment Strategies for Individuals with -Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association.

Gazzin A, Leoni C, Viscogliosi G, Borgini F, Perri L, Iacoviello M Genes (Basel). 2023; 14(12).

PMID: 38136956 PMC: 10742781. DOI: 10.3390/genes14122134.

References
1.
Boyle J, Makarov M, Podeszwa D, Rodgers J, Jo C, Birch J . Is Proximal Fibula Epiphysiodesis Necessary When Performing a Proximal Tibial Epiphysiodesis?. J Pediatr Orthop. 2020; 40(10):e984-e989. DOI: 10.1097/BPO.0000000000001642. View

2.
Kalish J, Biesecker L, Brioude F, Deardorff M, Di Cesare-Merlone A, Druley T . Nomenclature and definition in asymmetric regional body overgrowth. Am J Med Genet A. 2017; 173(7):1735-1738. PMC: 5932268. DOI: 10.1002/ajmg.a.38266. View

3.
Brioude F, Lacoste A, Netchine I, Vazquez M, Auber F, Audry G . Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr. 2013; 80(6):457-65. DOI: 10.1159/000355544. View

4.
Mussa A, Russo S, de Crescenzo A, Freschi A, Calzari L, Maitz S . Fetal growth patterns in Beckwith-Wiedemann syndrome. Clin Genet. 2016; 90(1):21-7. DOI: 10.1111/cge.12759. View

5.
Brioude F, Kalish J, Mussa A, Foster A, Bliek J, Ferrero G . Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018; 14(4):229-249. PMC: 6022848. DOI: 10.1038/nrendo.2017.166. View